22-Jan-2026
Download PDF
Marksans Pharma
The Company has scheduled a conference call for analysts and investors on Friday February 06 2026 at 04:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31 2025.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
